EANS-Adhoc: LifeWatch with solid first quarter 2013 results on track (with document)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Earnings/3-month report/LifeWatch AG
14.05.2013

+ Improved revenues of USD 21.02 million in Q1 2013;

+ Improved EBIT of USD 1.17 million and EBITDA of USD 1.95 million;

+ Improved gross margin of 59.1%;

+ Improved cash flow position in Q1 2013;

International analyst and media conference and audio web cast on
LifeWatch Q1 2013 results:

+ Tuesday, May 14, 2013 at 10.00 a.m. CEST; + Dial-in number: +41
(0)58 310 50 00 (Europe), +44 (0)203 059 58 62 (UK),+1(1)631 570 56
13 (USA); + Audio web cast
http://services.choruscall.eu/links/lifewatch130514.html;

Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE), the leading provider of wireless telemedicine, today
announces the results for the first quarter 2013. The Company
improves its operating profit on EBIT and EBITDA level and shows
again a net profit.

You will find a PDF-version of this press release and of the letter
to shareholders with the results of the first quarter 2013 at the end
of this message.

First Quarter 2013 Financial Highlights:

+ Revenues of USD 21.02 million compared with USD 20.07 million in Q4
2012;

+ Gross margin improved to 59.1% compared with 56.6% in Q4 2012;

+ EBIT improved to USD 1.17 million compared with USD 0.65 million in
Q4 2012;

+ EBITDA increased to USD 1.95 million compared with USD 1.57 million
in Q4 2012

+ Net profit of USD 0.14 million compared with USD 0.47 million in Q4
2012;

+ Cash from operations were USD 5.04 million compared with USD 1.13
million cash used in operations in Q4 2012

In March 2013, the Company announced that its Board member Kenneth
Melani will take the Chair of the Board of Directors subject to his
re-election at the upcoming ordinary shareholder meeting on May 29,
2013. Long-time Chairman and Chief Executive Officer of LifeWatch AG,
Dr. Yacov Geva, will continue to act as the Corporate CEO in order to
grow the existing and future business of the Company. The candidature
of John Paul announced by the Board of Directors on May 2, 2013, has
been withdrawn short-term by personal reasons.

Revenues:

Revenues in Q1 of 2013 were USD 21.02 million, compared with Q4 2012
revenues of USD 20.07 million. Total monitoring revenues from
LifeWatch Services grew by 6.3% compared with Q4 2012 revenues.

Gross Profit, EBIT and EBITDA:

+ Gross profit improved this quarter and reached USD 12.42 million
with a margin of 59.1%, compared with USD 11.36 million and a margin
of 56.6% in Q4 2012.

+ EBIT this quarter improved to USD 1.17 million or 5.6% of revenues,
compared with EBIT of USD 0.65 million with a margin of 3.2% reported
in Q4 2012.

+ EBITDA also improved in Q1 2013, reaching USD 1.95 million and a
margin of 9.3%, compared with EBITDA of USD 1.57 million and a margin
of 7.8% reported in Q4 2012.

Net Income:

Net income in Q1 2013 was USD 0.14 million and a margin of 0.6%,
compared with net income of USD 0.47 million with a margin of 2.3% in
Q4 2012. Fully diluted earnings per share reached USD 0.01 in Q1
2013, compared with fully diluted earnings per share of USD 0.03 in
Q4 2012.

Outlook 2013:

The company remains focused on improving revenues and profitability.
Our improved Q1 2013 results demonstrate our commitment to our
shareholders, and we are certain that the new product and service
pipeline will provide us with additional opportunities in diverse
geographies and consumer markets.

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
AG has operative subsidiaries in the United States, in Switzerland
and in Israel and is the parent company of LifeWatch Services Inc.,
and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a
leading US-based provider of cardiac monitoring services and home
sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch
Technologies Ltd., based in Israel, is a leading developer and
manufacturer of telemedicine products. The Company is planning to
introduce the LifeWatch V, an Android-based smartphone with medical
sensors and apps that uses a cloud-based service platform. For
additional information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/yvKBMcrX
http://resources.euroadhoc.com/us/VnwXYtUH

Further inquiry note:
Sensus Communication Consultants, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/yvKBMcrX
http://resources.euroadhoc.com/us/VnwXYtUH

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English